AI played a transformative role, particularly in biopharma, where it accounted for 30% of all healthcare investments.
Here are five things to know from the report:
- Biopharma AI investment led the charge, securing over $5 billion in funding—a 300% increase from 2023.
- Seed-stage investments made up 40% of all deals, with 35% of seed-stage companies leveraging AI, up from 25% in 2023.
- Established healthtech companies continued to attract significant funding, while newer startups faced pressure to demonstrate rapid success.
- Liquid biopsies and precision diagnostics emerged as promising areas.
- Hospital-focused innovations, particularly in imaging and monitoring, reinvigorated interest, overshadowing waning enthusiasm for wearables and home care devices.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
